Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
London, UK – March 1, 2023 - The Citeline Awards finalists have been announced prior to the Awards ceremony taking place at the Westin Boston Seaport District Hotel on Thursday, April 27, 2023.
These illustrious Awards celebrate and showcase significant innovations across the global biopharmaceutical industry. For 2023, there are two new awards categories, Excellence in Patient Recruitment and Engagement and Excellence in Use of Real-World Evidence; which join a range of categories acknowledging outstanding contributions across the entire R&D cycle.
View the full list of 2023 Citeline Awards shortlist and categories here.
Karen Currie, Executive Director, Editorial, Citeline: “A huge congratulations to all the companies, teams and individuals, who are finalists of this year’s Citeline Awards - it’s a fantastic achievement! A big thank you also goes to our judges, for their hard work and deliberation, I know they were very impressed by the volume and high-standard of this year’s entries.”
Returning for its 7th year, the Citeline Awards provides a unique platform for industry wide recognition and networking, for global leaders across the biopharmaceutical, CRO and diagnostic industries.
An independent judging panel of highly regarded professionals, representing a spectrum of R&D activities, reviewed and determined this year’s finalists. The winners will be presented their awards at a ceremony in Boston on April 27, 2023, attended by judges, finalists, winners and industry peers from around the world.
“Innovations like these play a significant role in clinical research and development. The Citeline Awards not only celebrate these accomplishments, but also highlight and encourage the importance of a more open, collaborative approach to R&D innovation. We look forward to bringing together the brightest industry minds this coming April.” said Karen Currie.
Citeline powers a full suite of complementary business intelligence offerings to meet the evolving needs of health science professionals to accelerate the connection of treatments to patients and patients to treatments. These patient-focused solutions and services deliver and analyse data used to drive clinical, commercial and regulatory related decisions and create real-world opportunities for growth.
Our global teams of analysts, journalists and consultants keep their fingers on the pulse of the pharmaceutical, biomedical and medtech industries, covering it all with expert insights: key diseases, clinical trials, drug R&D and approvals, market forecasts and more. For more information on one of the world’s most trusted health science partners, visit Citeline.
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.
Contact us for product technical and account support.
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: